FDA scientists opposed Trump administration’s move to ease peptide access
Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff…
Covered by 3 sources from 2 countries. First reported by ABC News ·
How 3 newspapers cover this story
FDA scientists opposed the Trump administration's effort to ease peptides access
Food and Drug Administration scientists did not support an effort by President Donald Trump's administration to loosen rules on unproven peptide drugs
FDA scientists opposed Trump administration’s move to ease peptide access
Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff…
RFK Jr. to ease access to unapproved peptides, draft policy states
Health and Human Services Secretary Robert F. Kennedy Jr. took steps Wednesday that could open up access to certain unapproved peptide drugs that are being promoted for wellness.
Coverage details
3 outlets from 2 countries are covering this story: ABC News, The Guardian and CBS News. ABC News published it first, on October 28, 2026; the last outlet to join was CBS News, 8 hours later.
Key names in the coverage: Trump, Human Services Secretary Robert F, Drug Administration, RFK Jr and Kennedy Jr.
By country: United States (2), United Kingdom (1).
